Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.

Here are some regions that are attracting biotech and pharma companies.

Krystal Biotech (KRYS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

Sen. Elizabeth Warren (D-Mass.) and Rep. Jan Schakowsky (D-Ill.) have introduced legislation that would require ...

Pharma companies also are known for paying dividends, offering you a guaranteed stream of annual revenue. Below are three ...

Deal volumes for pharmaceutical deals were lower in 2023 than they were 10 years ago and have been lower, on average, than ...

Two billion dollars in investments. 4,500 employees. Regeneron has grown into a major economic engine — and it's now ...

A potential three-year framework agreement between the Greek government and the pharmaceutical industry, starting at the ...

Some of the soundbite health care policy proposals that candidates bring up for short-term political impact could in practice ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.

“The RFK announcement has kind of scrambled some of the traditional thinking [about] a lot of the people that have been ...